These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
565 related articles for article (PubMed ID: 26248734)
21. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Tian Y; Nan Y; Han L; Zhang A; Wang G; Jia Z; Hao J; Pu P; Zhong Y; Kang C Int J Oncol; 2012 Apr; 40(4):1105-12. PubMed ID: 22179124 [TBL] [Abstract][Full Text] [Related]
22. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway. Li L; Zhang H Mol Med Rep; 2018 Mar; 17(3):4049-4056. PubMed ID: 29286115 [TBL] [Abstract][Full Text] [Related]
24. Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation. Peterziel H; Müller J; Danner A; Barbus S; Liu HK; Radlwimmer B; Pietsch T; Lichter P; Schütz G; Hess J; Angel P Neuro Oncol; 2012 Apr; 14(4):426-39. PubMed ID: 22394497 [TBL] [Abstract][Full Text] [Related]
25. Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer. Zhao C; Tao T; Yang L; Qin Q; Wang Y; Liu H; Song R; Yang X; Wang Q; Gu S; Xiong Y; Zhao D; Wang S; Feng D; Jiang WG; Zhang J; He J Cancer Lett; 2019 Jul; 453():107-121. PubMed ID: 30930234 [TBL] [Abstract][Full Text] [Related]
26. Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway. Guo LP; Zhang ZJ; Li RT; Li HY; Cui YQ Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):253-261. PubMed ID: 30657567 [TBL] [Abstract][Full Text] [Related]
27. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Fang J; Ding M; Yang L; Liu LZ; Jiang BH Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033 [TBL] [Abstract][Full Text] [Related]
28. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma. Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515 [TBL] [Abstract][Full Text] [Related]
29. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway. Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880 [TBL] [Abstract][Full Text] [Related]
30. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway. Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042 [TBL] [Abstract][Full Text] [Related]
32. miR‑181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma. Tang D; Gao W; Yang J; Liu J; Zhao J; Ge J; Chen Q; Liu B Mol Med Rep; 2020 Nov; 22(5):3804-3812. PubMed ID: 33000209 [TBL] [Abstract][Full Text] [Related]
33. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
35. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888 [TBL] [Abstract][Full Text] [Related]
36. Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells. Zhu G; Chai J; Ma L; Duan H; Zhang H Biochem Biophys Res Commun; 2013 Apr; 433(4):526-31. PubMed ID: 23524257 [TBL] [Abstract][Full Text] [Related]
38. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867 [TBL] [Abstract][Full Text] [Related]
39. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879 [TBL] [Abstract][Full Text] [Related]
40. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]